There are currently 14 active clinical trials seeking participants for Pulmonary Fibrosis research studies. The states with the highest number of trials for Pulmonary Fibrosis participants are California, Texas, Pennsylvania and New York.
Advancing Prevention of Pulmonary Fibrosis
NCT04564183
Recruiting
This study plans to learn more about pulmonary fibrosis and how it develops. We want to determine if the disease can be detected early, before the lung is permanently scarred. This study will enroll participants who are not currently diagnosed with pulmonary fibrosis, but who have family members with pulmonary fibrosis. Because there is an increased risk within affected families, this cohort will allow us to learn how pulmonary fibrosis develops, and how the lungs change over time.
Gender:
All
Ages:
Between 40 years and 75 years
Trial Updated:
09/27/2023
Locations: University of Colorado Anschutz Medical Campus, Aurora, Colorado
Conditions: IPF, Pulmonary Fibrosis, ILD
Register for Updates
Pulmonary Fibrosis Foundation Community Registry
NCT05382572
Recruiting
Pulmonary fibrosis (PF) results from a diverse group of health conditions and affects the lives of patients (including those who are post lung transplant), caregivers and family members. The Pulmonary Fibrosis Foundation Community Registry will offer an online portal where participants can self-enroll and directly contribute information about their experience with PF to be compiled into a longitudinal data set for use by researchers.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/28/2022
Locations: Pulmonary Fibrosis Foundation, Chicago, Illinois
Conditions: Pulmonary Fibrosis, Interstitial Lung Disease, Lung Fibrosis, Idiopathic Pulmonary Fibrosis
Register for Updates